GAD2 and Anxiety: The difference in AUC between pre-treatment screening data and weekly treatment data was significant for the GAD-2 [D = −2.35, p = 0.002], indicating that the GAD-2 had greater discriminative ability for anxiety in the weekly treatment measurements than during pre-treatment screening.